Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

Author:

Russell‐Jones David1ORCID,Dauchy Arnaud2,Delgado Elías345,Dimitriadis George6,Frandsen Hans A.7,Popescu Luiza8,Schultes Bernd9,Strojek Krzysztof10,Bonnemaire Mireille2,Roborel de Climens Aude11,Davies Melanie12ORCID

Affiliation:

1. Department of Diabetes and EndocrinologyRoyal Surrey County Hospital Guildford UK

2. Global Diabetes DivisionSanofi Paris France

3. Department of MedicineUniversity of Oviedo Spain

4. Endocrinology and Nutrition ServiceHospital Universitario Central de Asturias Oviedo Spain

5. Metabolism UnitInstituto de Investigación Sanitaria del Principado de Asturias (ISPA) Oviedo Spain

6. National and Kapodistrian University of Athens Medical SchoolAttikon University Hospital Athens Greece

7. Department of Internal MedicineAmager Hospital Copenhagen Denmark

8. Global R&D Operations Sanofi, Bucharest Romania

9. eSwiss Medical and Surgical Center, Department of Internal Medicine, EndocrinologyDiabetes and Metabolism, St Gallen Switzerland

10. Department of Internal DiseasesDiabetology and Cardiometabolic Diseases SMDZ, Zabrze, Silesian Medical University Katowice Poland

11. Clinical Outcome GenerationSanofi Lyon France

12. Diabetes Research Centre, University of LeicesterUniversity Hospitals of Leicester Leicester UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3